EXCLUSIVE-NETWORKS
Exclusive Networks today announced the appointments of four new Senior Vice Presidents to complement its existing global leadership team. The appointments of Gerard Allison (SVP, EMEA), Brad Gray (SVP, APAC), Scott Lewis (SVP, Americas) and Barrie Desmond (SVP Marketing & Communications) will provide strategic in-theatre leadership, supporting the company’s continuing success in offering unique local and global value, whilst driving future growth through market leading technologies, innovative services, and disruptive business models, creating value at scale for both vendors and channel partners alike.
“Gerard, Brad, Scott and Barrie are highly experienced operators who will make a valuable contribution to our business in 2020 and beyond,” said Olivier Breittmayer, CEO of Exclusive Networks. “Their arrival coincides with an exciting period of business transformation and innovation as we continue to scale-up and optimise our operational processes for renewed growth in disruptive service offerings, product portfolios and business models.”
Gerard Allison is a highly experienced senior executive with a 30+ year track record of building successful teams in EMEA, working at vendors such as Juniper Networks and, most recently, Gigamon. His extensive expertise and knowledge of the IT and security markets, commercial astuteness, entrepreneurial vision, relationship building and management skills, brings a wealth of experience to the EMEA business.
Brad Gray is a highly experienced senior executive with a 25+ year track record of building successful teams in APAC at vendors such as Juniper Networks, Polycom and, most recently, SAP. Having resided for 20 years in Singapore and for 3 years previously in Indonesia, Brad’s cultural, technological and commercial insights within the region brings a wealth of knowledge and expertise to the APAC business. His appointment comes as the former ‘Asia’ and ‘Pacific’ regions of Exclusive Networks combine as a single ‘APAC’ region.
Scott Lewis is a highly experienced senior executive with a 25+ year track record of regional sales and operations leadership in the Americas, having spent nearly 20 years in the cybersecurity sector working at vendors such as Blue Coat and IBM Internet Security Systems (ISS). Scott joins Exclusive from Fortinet where he spent the last 7 years leading its US Enterprise sales organisation and most recently its US West sales teams.
Barrie Desmond returns to Exclusive following a 12 month sabbatical having previously spent 7 years as Group Marketing Director and most recently as Chief Operations Officer. Barrie has over 30 years experience in marketing, communications and business development, having held senior management roles within channel and vendor organisations, with specialist knowledge and expertise in disruptive technologies and services in cybersecurity and cloud.
The new SVPs bring a wealth of expertise and experience to Exclusive Networks having held senior regional leadership roles at leading global channel and vendor organisations. Each report to Andy Travers, Executive Vice President, Worldwide Sales and Marketing.
“Our global footprint is significant and continually expanding, which emphasises the need for strong leadership at both local and regional levels,” said Andy Travers. “Gerard, Brad, Scott and Barrie are proven business leaders with a strong track record of success and I look forward to working closely with them to take advantage of the growth opportunities within their respective regions.
Their vast experience, knowledge and skills will be a tremendous asset to our business, our partners and our people as we continue to scale-up into a new decade.”
-ends-
About Exclusive Networks
Exclusive Networks is the global specialist VAD for cybersecurity and cloud solutions – the defining and interdependent technologies of the digital era. Its capabilities are backed by best-of-breed vendor portfolios, unparalleled skills and a host of compelling services from pre and post-sales technical support to leasing, training, professional services and global project management. With 50+ offices across five continents and presence in over 100 countries, Exclusive Networks has a unique ‘local sale, global scale’ model, enabling partners to achieve global reach, while delivering the added value of a locally-focused specialist distributor. More at www.exclusive-networks.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200108005671/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 13:00:00 CEST | Press release
– Vimseltinib demonstrated statistically significant and clinically meaningful benefit vs placebo in antitumor response – Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the dura
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 16:09:00 CEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 16:00:00 CEST | Press release
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2%Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary endpoints including pain and functionApplication for marketing authorization under review by China National Medical Products Administration (NMPA), with additional applications planned in the U.S. and other marketsNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the stud
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 15:04:00 CEST | Press release
- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Second pivotal development program of povetacicept underway with Phase 2b/3 trial initiation in primary membranous nephropathy - - Updated data from RUBY-3 trial of povetacicept accepted for late breaking oral presentation; inaxaplin study design and APOL1-mediated kidney disease related data accepted for poster presentation - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B c
Qualcomm Announces Quarterly Cash Dividend17.10.2025 15:00:00 CEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom